Yesterday, the Saudi Health Economics Experts Dialogue Forum, organized by the Saudi Scientific Society of Diabetes, was held at Foco Hotel in Riyadh. In which the Assistant Undersecretary of the Ministry of Health for Curative Affairs, Professor Ahmed Al-Judaya, revealed that many of the costs associated with the disease can be prevented by controlling lifestyle to reduce the spread of the disease and its complications, calling for priority to be given to initiatives such as preventing the spread of the disease and advising patients with diabetes, and what should be done It is used continuously to control the progression of the disease and its complications, to avoid increasing the medical, psychological and social costs of the disease.
He added: “One of the objectives of the Vision 2030 programs is to seek to control non-communicable diseases such as heart disease and diabetes by strengthening awareness programs, research, and national disease registries, and health care is generally measured based on indicators of health outcomes, such as the average lifespan of the individual, the extent of diabetes, and the costs of health spending. Health economics should be given the highest priority, because it provides the necessary and important information to decision-makers in the health system for the effective use of available resources to maximize health benefits.
The Vice-President of the Saudi Scientific Society for Diabetes, member of the Scientific Committee, Dr. Saud Al-Safiri delivered a speech in which he explained that the Kingdom has achieved an unprecedented achievement at the level of the Gulf and the Middle East, by launching the third forum for the Saudi Health Economics Experts Dialogue for two days, under the auspices of the Saudi Scientific Society for Diabetes, because it is the first initiative of the Its kind in the field of economics of treating diabetes and its complications. He added that the forum adopted a clear mechanism and specialized criteria for evaluating diabetes medications, within the framework of the objectives of the Kingdom’s Vision 2030, which aims to improve the quality and efficiency of health services and increase the effectiveness of diabetes medications.
Dr. Al-Sefri touched on the importance of addressing the gap represented in the lack of highly efficient assessment platforms in managing the costs of diabetes treatments in health facilities, noting that diabetes is the most common disease, and one of the biggest causes of death among the population in the Kingdom, while the cost of controlling Diabetes and its complications are one of the most burdens the country faces when choosing innovative and appropriate treatments for patients, pointing out that evaluating and comparing different drugs is based on the direct cost of the drug and its therapeutic properties together. Al-Sefri stressed that this scientific movement, which is organized and sponsored by the Saudi Scientific Society of Diabetes, is an extension of the ambitious plan launched by the wise leadership in the Kingdom’s Vision 2030.
At the conclusion of the opening ceremony, the speakers and participants in the conference, as well as the supporting bodies and sponsors of the conference, were honored.